Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
Please note that the ANZCTR website will be unavailable from 9am until 12:30pm (AEDT) on Tuesday 17th November for website maintenance.
Please be sure to log out of the system in order to avoid any loss of data. Thank you and apologies for any inconvenience caused.
A database of clinical trials and their results from Australia, New Zealand, and other countries.
account_circle
Log in
to register or update your trial
search
Search for trials
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12626001369314p
Ethics application status
Submitted, not yet approved
Date submitted
16/09/2026
Date registered
16/11/2026
Date last updated
16/11/2026
Date data sharing statement initially provided
16/11/2026
Type of registration
Prospectively registered
Titles & IDs
Public title
Integration of ultrasound to assess progress in labour: a randomised controlled trial.
The primary objective of this study is to demonstrate that the use of ultrasound to monitor progress in labour will reduce the rate of intrapartum pyrexia amongst nulliparous singleton women undergoing IOL at term.
Query!
Scientific title
The effect of labour progress assessment via integrated ultrasound on the rate of intrapartum pyrexia among nulliparous singleton women undergoing labour induction at term.
Query!
Additional trial identifiers [1]
318434
0
Nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
LABORUS
Query!
Related trial records
Query!
Health condition
Health condition(s) studied:
pregnancy
343600
0
Query!
childbirth complications
343603
0
Query!
Condition category
Condition code
Reproductive Health and Childbirth
339701
339701
0
0
Query!
Fetal medicine and complications of pregnancy
Query!
Reproductive Health and Childbirth
339893
339893
0
0
Query!
Childbirth and postnatal care
Query!
Reproductive Health and Childbirth
339894
339894
0
0
Query!
Other reproductive health and childbirth disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of the intervention or exposure
Pregnant women who have been scheduled for an induction of labour (IOL) will be invited to take part in this trial at the hospital. After obtaining informed written consent, participants will be randomly assigned to one of two arms: the progress of their labour will be assessed with digital vaginal examinations as per standard care, or labour progress will be assessed using ultrasound.
The device used will be a GE Voluson Swift or Voluson S8 ultrasound machine with a wide-band convex transducer. Standard non-invasive ultrasound gel and probe covers will be used in conjunction with the ultrasound machine. Participating women will be in a supine position and will be asked to flex and abduct their hips to allow transducer access.
Participants allocated to the ultrasound arm will still undergo a digital vaginal examination immediately prior to induction to assess the cervix. If required for specific procedures for the method of IOL or for specialised fetal interventions or for intrapartum clinical indications, digital vaginal examinations will still be performed.
Before the artificial rupture of the membrane (ARM)m Healthcare practitioners with extensive experience in ultrasound will perform a baseline scan assessing fetal biometry, Doppler parameters, amniotic fluid, and cervical length, followed by serial transabdominal and transperineal ultrasound assessments to monitor labor progress. These intrapartum scans are conducted every 12 hours prior to regular contractions or oxytocin initiation, increasing to every 4 hours during the latent phase of active labor, and every 2 hours during the active phase. Monitoring continues until sonographic cervical dilatation (SCD) reaches 10 cm or can no longer be visualized.
Throughout the trial, participants undergo systematic evaluations and data collection before, during, and after labor. Real-time pain and anxiety levels are assessed using physical acrylic Visual Analogue Scale (VAS) sliders and State-Trait Anxiety Inventory (STAI) forms prior to and immediately following each examination. Within 72 hours of delivery, participants complete the Client Satisfaction Questionnaire (CSQ-8) and the Satisfaction with Examinations in Labor Questionnaire to evaluate their overall birth experience. Immediately following birth, clinical data—including neonatal birthweight, Apgar scores, umbilical cord arterial pH, and placental pathology or swabs in cases of suspected infection—are recorded. Finally, a two-week post-delivery follow-up phone call is conducted to re-evaluate patient satisfaction and identify any readmissions, postpartum fever, or endometritis.
Every scheduled intrapartum ultrasound scan and digital vaginal examination (VE) is recorded in an electronic Case Record Form (eCRF) in REDCap. The system logs the exact timing, frequency, indication, and specific ultrasound measurements (e.g., parasagittal angle of progression (psAOP), head perineum distance (HPD), SCD) for each session, allowing real-time tracking of whether scans occur according to the protocol-mandated intervals.
Query!
Intervention code [1]
335336
0
Diagnosis / Prognosis
Query!
Intervention code [2]
335337
0
Treatment: Devices
Query!
Description of the comparator or control
Women allocated to the control group will undergo digital vaginal examinations from ARM onwards until caesarean section or operative vaginal delivery by experienced healthcare practitioners at the hospital. Based on standard clinical practice the VEs will be conducted every 4 hours during the latent phase and active labour or whenever clinically indicated to check cervical dilatation and fetal head position until the baby is delivered.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
346875
0
Rate of pyrexia during IOL in singleton pregnancies when compared to current standard of care.
Query!
Assessment method [1]
346875
0
Body temperature measured during labour of more than 38C, measured with a digital thermometer.
Query!
Timepoint [1]
346875
0
Intrapartum, from the moment of the artificial rupture of the membrane throughout the course of labour during the induction process until the baby is delivered.
Query!
Secondary outcome [1]
467985
0
Readmissions
Query!
Assessment method [1]
467985
0
Follow up survey via phone call with cross-reference to health records
Query!
Timepoint [1]
467985
0
Two weeks after delivery
Query!
Secondary outcome [2]
467986
0
Baby's APGAR score
Query!
Assessment method [2]
467986
0
APGAR test
Query!
Timepoint [2]
467986
0
at 5 minutes and at 10 minutes after delivery
Query!
Secondary outcome [3]
467987
0
NICU admissions
Query!
Assessment method [3]
467987
0
Recording of admission to the NICU or special care nursery, along with length of stay.
Query!
Timepoint [3]
467987
0
Postpartum during the hospital stay up to discharge
Query!
Secondary outcome [4]
469391
0
Maternal pain level during assessment of progress in labour
Query!
Assessment method [4]
469391
0
Measured using a Visual Analogue Scale (VAS) pain score (0–10 scale) using a physical acrylic slider tool
Query!
Timepoint [4]
469391
0
Evaluated immediately post-examination (after each vaginal examination or ultrasound assessment)
Query!
Secondary outcome [5]
469392
0
Maternal overall satisfaction with labor examinations and birth experience
Query!
Assessment method [5]
469392
0
A composite assessment using two standardized questionnaires: the Client Satisfaction Questionnaire (CSQ-8) and the Satisfaction with Examinations in Labor Questionnaire.
Query!
Timepoint [5]
469392
0
Administered twice: - Within 72 hours post-delivery (prior to discharge) - During a 2-week post-delivery follow-up phone call
Query!
Secondary outcome [6]
469393
0
Maternal anxiety associated with labour monitoring
Query!
Assessment method [6]
469393
0
A composite assessment measured using a Visual Analogue Scale (VAS) Anxiety slider and the State-Trait Anxiety Inventory (STAI) short-form questionnaire
Query!
Timepoint [6]
469393
0
Administered immediately before and after each examination (digital vaginal examination or ultrasound scan) during labour
Query!
Secondary outcome [7]
469394
0
Neonatal Infection or Sepsis
Query!
Assessment method [7]
469394
0
Monitoring and diagnosis of the participant and review of their electronic health records.
Query!
Timepoint [7]
469394
0
Monitored during the initial hospital stay and evaluated up to the 2-week follow-up call
Query!
Secondary outcome [8]
469600
0
Endometritis
Query!
Assessment method [8]
469600
0
Evaluated during the telephone survey administered to the participant and cross-referenced with electronic health records
Query!
Timepoint [8]
469600
0
Two week post-delivery follow-up phone call
Query!
Eligibility
Key inclusion criteria
Nulliparous women with a singleton pregnancy and gestation >37 weeks due to undergoing IOL.
Cephalic presentation and intact membrane.
Informed consent provided.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Females
Query!
Healthy volunteers
No
Query!
Key exclusion criteria
Women younger than 18 years
Women pregnant with a breech presentation
Women who are unconscious or severely ill
Women with learning difficulties or serious mental illness
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Central randomisation
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer-generated random sequence
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
A previous study showed a reduction of 60% in pyrexia in labour among women undergoing ultrasound to monitor progress in labour. Anticipating that intrapartum ultrasound would reduce the relative rate of the primary objective by 45% or greater (conservatory approach), equivalent to a rate of 11%, it was estimated that 506 participants would be needed in total for an 80% power, a confidence level of 95%, at an allocation ratio of 1:1 (standard of care: ultrasound), assuming a post randomisation loss to follow-up/withdraw rate of 15%, recruitment of 595 participants will be needed, approximating to a 600 participants sample size.
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
16/11/2026
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
15/10/2029
Query!
Actual
Query!
Date of last data collection
Anticipated
15/11/2029
Query!
Actual
Query!
Sample size
Target
600
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
30218
0
Monash Medical Centre - Clayton campus - Clayton
Query!
Recruitment postcode(s) [1]
46612
0
3168 - Clayton
Query!
Recruitment outside Australia
Country [1]
28543
0
Spain
Query!
State/province [1]
28543
0
Madrid
Query!
Country [2]
28544
0
Hong Kong
Query!
State/province [2]
28544
0
Shatin District, New Territories
Query!
Country [3]
28545
0
France
Query!
State/province [3]
28545
0
Paris
Query!
Country [4]
28546
0
Italy
Query!
State/province [4]
28546
0
Parma
Query!
Country [5]
28547
0
Switzerland
Query!
State/province [5]
28547
0
Basel
Query!
Funding & Sponsors
Funding source category [1]
323035
0
Other Collaborative groups
Query!
Name [1]
323035
0
Hospital Universitario de Torrejon
Query!
Address [1]
323035
0
Query!
Country [1]
323035
0
Spain
Query!
Primary sponsor type
Individual
Query!
Name
Dr Pongsarat Sukjit - Monash Health
Query!
Address
Query!
Country
Australia
Query!
Secondary sponsor category [1]
325952
0
Individual
Query!
Name [1]
325952
0
Prof. Daniel Rolnik - Monash Health
Query!
Address [1]
325952
0
Query!
Country [1]
325952
0
Australia
Query!
Ethics approval
Ethics application status
Submitted, not yet approved
Query!
Ethics committee name [1]
321422
0
Monash Health Human Research Ethics Committee A
Query!
Ethics committee address [1]
321422
0
https://monashhealth.org/research/resources/resource-library/
Query!
Ethics committee country [1]
321422
0
Australia
Query!
Date submitted for ethics approval [1]
321422
0
16/09/2026
Query!
Approval date [1]
321422
0
Query!
Ethics approval number [1]
321422
0
Query!
Summary
Brief summary
Assessment of labour progress in pregnant women who are undergoing induction of labour is traditionally performed using digital vaginal examinations that can be uncomfortable and may contribute to infection risk during labour. Recent research suggests that ultrasound may be a reliable alternative to assess labour progress. This randomised clinical trial aims to determine whether using ultrasound can be used instead of digital vaginal examinations to assess the progress of labour; has an impact on discomfort and anxiety during labour assessments or has an effect on women's birth experience; reduces fever during labour and reduces infection-related complications.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
153670
0
Dr Pongsarat Sukjit
Query!
Address
153670
0
Monash Health, 246 Clayton Road, Clayton VIC 3168
Query!
Country
153670
0
Australia
Query!
Phone
153670
0
+61 452 644 239
Query!
Fax
153670
0
Query!
Email
153670
0
[email protected]
Query!
Contact person for public queries
Name
153671
0
Pongsarat Sukjit
Query!
Address
153671
0
Monash Health, 246 Clayton Road, Clayton VIC 3168
Query!
Country
153671
0
Australia
Query!
Phone
153671
0
+61 3 9594 6666
Query!
Fax
153671
0
Query!
Email
153671
0
[email protected]
Query!
Contact person for scientific queries
Name
153672
0
Pongsarat Sukjit
Query!
Address
153672
0
Monash Health, 246 Clayton Road, Clayton VIC 3168
Query!
Country
153672
0
Australia
Query!
Phone
153672
0
+61 3 9594 6666
Query!
Fax
153672
0
Query!
Email
153672
0
[email protected]
Query!
Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
•
Researchers
Conditions for requesting access:
•
Yes, conditions apply:
•
Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
•
Requires a scientifically sound proposal or protocol
•
Requires approval by an ethics committee
•
Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
•
De-identified individual participant data:
•
All outcomes data
•
Published results
•
Primary outcome(s)
What types of analyses could be done with individual participant data?
•
Systematic reviews and meta-analyses
•
Studies exploring new research questions
•
Health economic analyses
•
Studies testing whether findings can be repeated or confirmed
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
Not yet decided
Where can requests to access individual participant data be made, or data be obtained directly?
•
Email of trial custodian, sponsor or committee:
[email protected]
Are there extra considerations when requesting access to individual participant data?
No
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF